Treatment to lower platelet adhesiveness

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01)

Patent

CA 2367041

A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example <u>N</u>,<u>N</u>- dimethyl-1[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for decreasing platelet adhesiveness.

L'invention concerne un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable dudit composé. Dans cette formule, R¿1? et R¿2? représentent chacun indépendamment H ou méthyle (notamment un hydrochlorure de ~u~N~/u~,~u~N~/u~-diméthyl-1[1-(4-chlorophényl)cyclobutyl]-3-méthylbutyl amine, éventuellement sous sa forme monohydratée). Ledit composé est utilisé pour réduire l'adhésivité plaquettaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment to lower platelet adhesiveness does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment to lower platelet adhesiveness, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment to lower platelet adhesiveness will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1415240

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.